SCHEDULE: FMR LLC Discloses 9.8% Stake in Exact Sciences Corp
Beneficial Ownership Report
FMR LLC and its affiliates, including Abigail P. Johnson, reported a beneficial ownership of 9.8% in Exact Sciences Corp, totaling over 18.5 million shares.
Summary
- FMR LLC and its affiliates, including Abigail P. Johnson, beneficially own 18,588,183.06 shares of Exact Sciences Corp common stock.
- This represents 9.8% of the total outstanding common stock of Exact Sciences Corp.
- FMR LLC holds sole voting power over 17,584,537.69 shares and sole dispositive power over 18,588,183.06 shares.
- Abigail P. Johnson is deemed to have sole dispositive power over 18,588,183.06 shares due to her role as Director, Chairman, and CEO of FMR LLC, and the Johnson family's controlling interest in FMR LLC.
- This filing is an Amendment No. 2 to a previous Schedule 13G, indicating an update to their reported beneficial ownership.
Sentiment
Score: 7
Explanation: The filing indicates a significant, continued institutional investment by a major asset manager, FMR LLC, in Exact Sciences Corp. This generally signals confidence and stability, which is a positive indicator for the company's stock, although it is a routine disclosure and not a new investment decision.
Positives
- Significant institutional ownership by FMR LLC, a major investment management firm, signals confidence in Exact Sciences Corp.
- The substantial stake of 9.8% indicates a long-term investment perspective rather than a short-term trading position.
Negatives
- No specific negative information regarding Exact Sciences Corp's operations or financial performance is disclosed in this beneficial ownership report.
Risks
- No specific risks related to Exact Sciences Corp's operations or financial health are disclosed in this filing, as it pertains solely to beneficial ownership.
Future Outlook
NA
Industry Context
The disclosure of a significant stake by a major institutional investor like FMR LLC in a healthcare diagnostics company such as Exact Sciences Corp can be viewed positively, suggesting a belief in the company's long-term growth prospects within the evolving healthcare sector.
Comparison to Industry Standards
- FMR LLC's 9.8% stake in Exact Sciences Corp is a substantial position for an institutional investor, often indicating a high-conviction investment. For comparison, other large asset managers like BlackRock or Vanguard frequently hold similar or larger passive stakes in major companies as part of their index or actively managed funds.
- The beneficial ownership percentage is below the 10% threshold that would typically trigger a Schedule 13D filing, which implies a more active role or intent to influence management. This 13G filing suggests a passive investment intent, consistent with the ordinary course of business for a large asset manager.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director, Chairman, Chief Executive Officer | NA | Abigail P. Johnson | NA | Abigail P. Johnson's role at FMR LLC is noted as part of the beneficial ownership disclosure, not a change in personnel at Exact Sciences Corp or FMR LLC. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Structure Disclosure | Disclosure that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares of FMR LLC (49% voting power) and have a shareholders' voting agreement, forming a controlling group for FMR LLC. | NA | Clarifies the control structure of FMR LLC, the reporting entity, and explains why Abigail P. Johnson is deemed to have beneficial ownership of the shares held by FMR LLC. |
Stakeholder Impact
- Shareholders of Exact Sciences Corp may view the significant institutional ownership by FMR LLC as a positive signal, potentially increasing investor confidence and stability in the stock.
- The disclosure provides transparency to the market regarding major institutional holdings, which can influence trading decisions.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 01/10/2023 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000003) was incorporated by reference. |
| 01/26/2023 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 01/31/2023 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000038) for Abigail P. Johnson was incorporated by reference. |
| 08/29/2025 | Date of event which required the filing of this statement. |
| 09/05/2025 | Date of signing and filing of this Schedule 13G Amendment No. 2. |
Recommendation
holdThe filing is a routine Schedule 13G amendment disclosing a significant, but not new, beneficial ownership stake by FMR LLC. While substantial institutional ownership is generally a positive indicator of confidence, this specific filing does not present new information that would fundamentally alter the investment thesis for Exact Sciences Corp to warrant a 'buy' or 'sell' recommendation. It confirms a continued strong institutional presence, suggesting a 'hold' for existing investors and a neutral stance for potential new investors until further operational or financial news emerges.
Keywords
Exact Sciences Corp, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management, Healthcare Diagnostics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.